The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
dc.contributor.author | Ueda, Peter | |
dc.contributor.author | Wintzell, Viktor | |
dc.contributor.author | Dahlqwist, Elisabeth | |
dc.contributor.author | Eliasson, Björn | |
dc.contributor.author | Svensson, Ann-Marie | |
dc.contributor.author | Franzén, Stefan | |
dc.contributor.author | Gudbjörnsdottir, Soffia | |
dc.contributor.author | Hveem, Kristian | |
dc.contributor.author | Jonasson, Christian | |
dc.contributor.author | Melbye, Mads | |
dc.contributor.author | Hviid, Anders | |
dc.contributor.author | Svanström, Henrik | |
dc.contributor.author | Pasternak, Björn | |
dc.date.accessioned | 2022-02-07T07:24:20Z | |
dc.date.available | 2022-02-07T07:24:20Z | |
dc.date.created | 2021-12-02T14:08:54Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Diabetes, obesity and metabolism. 2021, 1-13. | |
dc.identifier.issn | 1462-8902 | |
dc.identifier.uri | https://hdl.handle.net/11250/2977335 | |
dc.language.iso | eng | |
dc.title | The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-13 | |
dc.source.journal | Diabetes, obesity and metabolism | |
dc.identifier.doi | 10.1111/dom.14598 | |
dc.identifier.cristin | 1963490 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 |
Tilhørende fil(er)
Denne innførselen finnes i følgende samling(er)
-
Artikler [5061]
-
Publikasjoner fra CRIStin FHI [7531]